tiprankstipranks
MiNK Therapeutics (INKT)
NASDAQ:INKT
US Market
INKT
MiNK Therapeutics
RESEARCH TOOLSreports
Want to see INKT full AI Analyst Report?

MiNK Therapeutics (INKT) Income Statement

264 Followers

MiNK Therapeutics Income Statement

Last quarter (Q4 2025), MiNK Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, MiNK Therapeutics's net income was $-2.60M. See MiNK Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -181.75K$ -215.44K$ -204.62K$ -121.75K$ -77.96K
Operating Expenses
$ 12.31M$ 10.43M$ 22.72M$ 30.83M$ 18.53M
Depreciation and Amortization
$ 181.75K$ 215.44K$ 204.62K$ 121.75K$ 77.96K
EBITDA
$ -12.31M$ -10.57M$ -22.25M$ -27.87M$ -27.70M
Operating Income
$ -12.49M$ -10.65M$ -22.92M$ -30.95M$ -18.61M
Other Income/Expenses
$ -6.96K$ -134.56K$ 463.25K$ 2.96M$ -11.61M
Pretax Income
$ -12.49M$ -10.78M$ -22.46M$ -27.99M$ -30.21M
Net Income
$ -12.49M$ -10.78M$ -22.46M$ -27.99M$ -30.21M
Per Share Metrics
Basic EPS
$ -2.93$ -2.90$ -6.54$ -8.31$ -9.03
Diluted EPS
$ -2.93$ -2.80$ -6.54$ -8.31$ -9.03
Weighted Average Shares Outstanding
 4.27M 3.74M 3.44M 3.37M 3.35M
Weighted Average Shares Outstanding (Diluted)
 4.27M 3.86M 3.44M 3.37M 3.35M
Currency in USD

MiNK Therapeutics Earnings and Revenue History